1. Home
  2. XNCR vs DHC Comparison

XNCR vs DHC Comparison

Compare XNCR & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$33.57

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

N/A

Current Price

$7.05

Market Cap

1.9B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
XNCR
DHC
Founded
1997
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2013
1998

Fundamental Metrics

Financial Performance
Metric
XNCR
DHC
Price
$33.57
$7.05
Analyst Decision
Buy
Buy
Analyst Count
14
5
Target Price
★ $43.83
$9.88
AVG Volume (30 Days)
1.5M
★ 1.6M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
N/A
★ 0.57%
EPS Growth
★ 65.36
23.23
EPS
N/A
★ N/A
Revenue
$125,576,000.00
★ $1,074,819,000.00
Revenue This Year
$58.19
N/A
Revenue Next Year
N/A
$5.01
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 13.65
1.59
52 Week Low
$10.38
$4.51
52 Week High
$40.60
$9.66

Technical Indicators

Market Signals
Indicator
XNCR
DHC
Relative Strength Index (RSI) 54.03 36.54
Support Level $22.80 $6.92
Resistance Level $33.60 $7.59
Average True Range (ATR) 2.08 0.33
MACD -0.54 -0.02
Stochastic Oscillator 35.21 30.28

Price Performance

Historical Comparison
XNCR
DHC

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.

Share on Social Networks: